{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:54:46Z","timestamp":1792234486931,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-023-10326-1","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T03:32:46Z","timestamp":1688009566000},"page":"1395-1403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sacubitril\/valsartan and arrhythmic burden in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9819-2148","authenticated-orcid":false,"given":"A.","family":"Pozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Abete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tavano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Iacovoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"issue":"8","key":"10326_CR1","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen A, Rutten FH, Mosterd A, Hoes AW (2020) Epidemiology of heart failure. Eur J Heart Fail 22(8):1342\u20131356","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10326_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH (2017) Global public health burden of heart failure. Card Fail Rev 3(1):7\u201311","journal-title":"Card Fail Rev"},{"key":"10326_CR3","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J"},{"issue":"11","key":"10326_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993\u20131004","journal-title":"N Engl J Med"},{"issue":"21","key":"10326_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995\u20132008","journal-title":"N Engl J Med"},{"issue":"15","key":"10326_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383(15):1413\u20131424","journal-title":"N Engl J Med"},{"issue":"2","key":"10326_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.121.054034","volume":"144","author":"GM Felker","year":"2021","unstructured":"Felker GM, Butler J, Ibrahim NE, Pi\u00f1a IL, Maisel A, Bapat D et al (2021) Implantable cardioverter-defibrillator eligibility after initiation of sacubitril\/valsartan in chronic heart failure: insights from PROVE-HF. Circulation 144(2):180\u2013182","journal-title":"Circulation"},{"issue":"11","key":"10326_CR8","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","volume":"139","author":"DH Kang","year":"2019","unstructured":"Kang DH, Park SJ, Shin SH, Hong GR, Lee S, Kim MS et al (2019) Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation. Circulation 139(11):1354\u20131365","journal-title":"Circulation"},{"issue":"4","key":"10326_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/01.CIR.72.4.681","volume":"72","author":"M Packer","year":"1985","unstructured":"Packer M (1985) Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 72(4):681\u2013685","journal-title":"Circulation"},{"issue":"18","key":"10326_CR10","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/eurheartj\/ehz553","volume":"41","author":"M Packer","year":"2020","unstructured":"Packer M (2020) What causes sudden death in patients with chronic heart failure and a reduced ejection fraction? Eur Heart J 41(18):1757\u20131763","journal-title":"Eur Heart J"},{"issue":"1","key":"10326_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1609758","volume":"377","author":"L Shen","year":"2017","unstructured":"Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF et al (2017) Declining risk of sudden death in heart failure. N Engl J Med 377(1):41\u201351","journal-title":"N Engl J Med"},{"issue":"18","key":"10326_CR12","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/eurheartj\/ehz553","volume":"41","author":"M Packer","year":"2019","unstructured":"Packer M (2019) What causes sudden death in patients with chronic heart failure and a reduced ejection fraction? Eur Heart J 41(18):1757\u20131763","journal-title":"Eur Heart J"},{"issue":"1","key":"10326_CR13","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1016\/j.hrthm.2019.03.014","volume":"17","author":"EM Cronin","year":"2020","unstructured":"Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N et al (2020) 2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary. Heart Rhythm 17(1):e155\u2013e205","journal-title":"Heart Rhythm"},{"issue":"10","key":"10326_CR14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s00392-019-01440-y","volume":"108","author":"P Martens","year":"2019","unstructured":"Martens P, Nuyens D, Rivero-Ayerza M, Van Herendael H, Vercammen J, Ceyssens W et al (2019) Sacubitril\/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction. Clin Res Cardiol 108(10):1074\u20131082","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"10326_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.hrthm.2017.11.012","volume":"15","author":"C de Diego","year":"2018","unstructured":"de Diego C, Gonz\u00e1lez-Torres L, N\u00fa\u00f1ez JM, Centuri\u00f3n Inda R, Martin-Langerwerf DA, Sangio AD et al (2018) Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices. Heart Rhythm 15(3):395\u2013402","journal-title":"Heart Rhythm"},{"issue":"4","key":"10326_CR16","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/jcm9041111","volume":"9","author":"V Russo","year":"2020","unstructured":"Russo V, Bottino R, Rago A, Papa AA, Liccardo B, Proietti R et al (2020) The effect of sacubitril\/valsartan on device detected arrhythmias and electrical parameters among dilated cardiomyopathy patients with reduced ejection fraction and implantable cardioverter defibrillator. J Clin Med 9(4):1111","journal-title":"J Clin Med"},{"issue":"3","key":"10326_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ejhf.2419","volume":"24","author":"JP Curtain","year":"2022","unstructured":"Curtain JP, Jackson AM, Shen L, Jhund PS, Docherty KF, Petrie MC et al (2022) Effect of sacubitril\/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF. Eur J Heart Fail 24(3):551\u2013561","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10326_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","volume":"57","author":"L Iles","year":"2011","unstructured":"Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM et al (2011) Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 57(7):821\u2013828","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10326_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","volume":"4","author":"MA Konstam","year":"2011","unstructured":"Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE (2011) Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 4(1):98\u2013108","journal-title":"JACC Cardiovasc Imaging"},{"key":"10326_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2261-13-52","volume":"13","author":"M Al-Gobari","year":"2013","unstructured":"Al-Gobari M, El Khatib C, Pillon F, Gueyffier F (2013) \u03b2-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 13:52","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10326_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145958","volume":"11","author":"HH Le","year":"2016","unstructured":"Le HH, El-Khatib C, Mombled M, Guitarian F, Al-Gobari M, Fall M et al (2016) Impact of aldosterone antagonists on sudden cardiac death prevention in heart failure and post-myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE 11(2):e0145958","journal-title":"PLoS ONE"},{"issue":"18","key":"10326_CR22","first-page":"1794","volume":"377","author":"L Shen","year":"2017","unstructured":"Shen L, Jhund PS, McMurray JJV (2017) Declining risk of sudden death in heart failure. N Engl J Med 377(18):1794\u20131795","journal-title":"N Engl J Med"},{"issue":"11","key":"10326_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","volume":"133","author":"SA Hubers","year":"2016","unstructured":"Hubers SA, Brown NJ (2016) Combined angiotensin receptor antagonism and neprilysin inhibition. Circulation 133(11):1115\u20131124","journal-title":"Circulation"},{"issue":"7","key":"10326_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","volume":"73","author":"MR Zile","year":"2019","unstructured":"Zile MR, O\u2019Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K et al (2019) Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF. J Am Coll Cardiol 73(7):795\u2013806","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10326_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1161\/CIRCULATIONAHA.121.054892","volume":"144","author":"KF Docherty","year":"2021","unstructured":"Docherty KF, Campbell RT, Brooksbank KJM, Dreisbach JG, Forsyth P, Godeseth RL et al (2021) Effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. Circulation 144(3):199\u2013209","journal-title":"Circulation"},{"issue":"11","key":"10326_CR26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jama.2019.12821","volume":"322","author":"JL Januzzi Jr","year":"2019","unstructured":"Januzzi JL Jr, Prescott MF, Butler J, Felker GM, Maisel AS, McCague K et al (2019) Association of change in n-terminal pro-b-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction. JAMA 322(11):1085\u20131095","journal-title":"JAMA"},{"issue":"2","key":"10326_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","volume":"69","author":"T Nishikimi","year":"2006","unstructured":"Nishikimi T, Maeda N, Matsuoka H (2006) The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69(2):318\u2013328","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10326_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002423","volume":"4","author":"R Kerkel\u00e4","year":"2015","unstructured":"Kerkel\u00e4 R, Ulvila J, Magga J (2015) Natriuretic peptides in the regulation of cardiovascular physiology and metabolic events. J Am Heart Assoc 4(10):e002423","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10326_CR29","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCRESAHA.117.310083","volume":"120","author":"AP Landstrom","year":"2017","unstructured":"Landstrom AP, Dobrev D, Wehrens XHT (2017) Calcium signaling and cardiac arrhythmias. Circ Res 120(12):1969\u20131993","journal-title":"Circ Res"},{"issue":"6","key":"10326_CR30","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/0735-1097(94)00553-3","volume":"25","author":"A Hallstrom","year":"1995","unstructured":"Hallstrom A, Pratt CM, Greene HL, Huther M, Gottlieb S, DeMaria A et al (1995) Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial. J Am Coll Cardiol 25(6):1250\u20131257","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10326_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0167-5273(99)00088-1","volume":"70","author":"J Niebauer","year":"1999","unstructured":"Niebauer J, Clark AL, Anker SD, Coats AJ (1999) Three year mortality in heart failure patients with very low left ventricular ejection fractions. Int J Cardiol 70(3):245\u2013247","journal-title":"Int J Cardiol"},{"issue":"5","key":"10326_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1536\/jhj.45.771","volume":"45","author":"I Sutovsky","year":"2004","unstructured":"Sutovsky I, Katoh T, Ohno T, Honma H, Takayama H, Takano T (2004) Relationship between brain natriuretic peptide, myocardial wall stress, and ventricular arrhythmia severity. Jpn Heart J 45(5):771\u2013777","journal-title":"Jpn Heart J"},{"issue":"15","key":"10326_CR33","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/01.CIR.0000065226.24159.E9","volume":"107","author":"MG St John Sutton","year":"2003","unstructured":"St John Sutton MG, Plappert T, Abraham WT, Smith AL, De Lurgio DB, Leon AR et al (2003) Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107(15):1985\u20131990","journal-title":"Circulation"},{"issue":"41","key":"10326_CR34","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/eurheartj\/ehv373","volume":"36","author":"NA Chatterjee","year":"2015","unstructured":"Chatterjee NA, Roka A, Lubitz SA, Gold MR, Daubert C, Linde C et al (2015) Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review. Eur Heart J 36(41):2780\u20132789","journal-title":"Eur Heart J"},{"issue":"1","key":"10326_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000046777.74753.F8","volume":"107","author":"M Hodges","year":"2003","unstructured":"Hodges M, Bailey JJ, Church TR (2003) B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 107(1):e13","journal-title":"Circulation"},{"issue":"30","key":"10326_CR36","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","volume":"36","author":"AS Desai","year":"2015","unstructured":"Desai AS, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Chen F et al (2015) Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur Heart J 36(30):1990\u20131997","journal-title":"Eur Heart J"},{"issue":"12","key":"10326_CR37","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jacc.2016.06.052","volume":"68","author":"SK Sinha","year":"2016","unstructured":"Sinha SK, Crain B, Flickinger K, Calkins H, Rickard J, Cheng A et al (2016) Clinical inferences of cardiovascular implantable electronic device analysis at autopsy. J Am Coll Cardiol 68(12):1255\u20131264","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10326_CR38","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","volume":"359","author":"JE Poole","year":"2008","unstructured":"Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359(10):1009\u20131017","journal-title":"N Engl J Med"},{"key":"10326_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.890481","volume":"9","author":"R Wang","year":"2022","unstructured":"Wang R, Ye H, Ma L, Wei J, Wang Y, Zhang X et al (2022) Effect of sacubitril\/valsartan on reducing the risk of arrhythmia: a systematic review and meta-analysis of randomized controlled trials. Front Cardiovasc Med 9:890481","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"10326_CR40","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.19102\/icrm.2022.130905","volume":"13","author":"H Mujadzic","year":"2022","unstructured":"Mujadzic H, Prousi GS, Napier R, Siddique S, Zaman N (2022) The impact of angiotensin receptor-neprilysin inhibitors on arrhythmias in patients with heart failure: a systematic review and meta-analysis. J Innov Card Rhythm Manag 13(9):5164\u20135175","journal-title":"J Innov Card Rhythm Manag"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10326-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-023-10326-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10326-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:15:08Z","timestamp":1697184908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-023-10326-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["10326"],"URL":"https:\/\/doi.org\/10.1007\/s10741-023-10326-1","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"6 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}